Hot Products
| Catalog No. | Information |
| CFN95299 | Glaucoside A Anticancer. Glaucoside A was evaluated against the HT-29 and HCT 116 human colon cancer cell lines. |
| CFN95300 | Glaucoside C Anticancer. Glaucoside C was evaluated against the HT-29 and HCT 116 human colon cancer cell lines. |
| CFN97977 | Glepidotin B Reference standards. |
| CFN80103 | Glibenclamide Glibenclamide is a known blocker of vascular ATP-sensitive K+ channels (KATP), used in the treatment of type 2 diabetes.Glibenclamide increases the risk for hypoglycemia by increasing insulin secretion, it plays a paradoxical protective role to protect against severe hypoglycemia-induced fatal cardiac arrhythmias; it also reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. |
| CFN95063 | Glicoricone Glicoricone acts as a partial estrogen antagonist. Glicoricone inhibited the monoamine oxidase with the IC50 values of 6.0 x 10(-5)-1.4 x 10(-4) M. |
| CFN93993 | Gliotoxin Gliotoxin, a Wnt signaling pathway inhibitor, induces growth inhibition and apoptosis in multiple colorectal cancer cell lines with mutations of the Wnt signaling pathway. Gliotoxin targets nuclear NOTCH2 in human solid tumor derived cell lines in vitro and inhibits melanoma growth in xenograft mouse model. Gliotoxin exhibits very strong anti-tuberculosis activity towards Mycobacterium tuberculosis with the the prominent MIC50 value of <0.03 uM. Gliotoxin also suppresses macrophage immune function by subverting phosphatidylinositol 3,4,5-trisphosphate homeostasis. |
| CFN96591 | Globulol Globulol shows antimicrobial activity against Xanthomonas vesicatoria and Bacillus subtilis, the IC50 value of 158.0 microg/ mLand 737.2 microg/ mL, respectively. |
| CFN00499 | Glucoalyssin |
| CFN00497 | Glucobarbarin |
| CFN00495 | Glucoberteroin |
